1 / 2

Thrombin Market Size & Share

Thrombin Market Size & Share

Manisha109
Download Presentation

Thrombin Market Size & Share

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Thrombin Market Analysis The global thrombin market is projected to grow from $713.4 million in 2025 to $983.3 million in 2032, expanding at a CAGR of 4.7%. Market Overview Thrombin plays a vital role in blood clot formation by converting fibrinogen to fibrin. The market growth is driven by increasing surgical procedures and trauma cases requiring hemostasis. Key Market Segments By Product Type  Recombinant Thrombin: Dominated the market in 2024, driven by supply chain disruptions of human-derived products and safety concerns  Human Thrombin: Second-largest segment, growing due to increasing surgical interventions  Bovine Thrombin: Slower growth due to associated adverse effects By Dosage Form  Powder Form: Market leader due to longer shelf life and ease of storage  Solution Form: Growing steadily due to precise delivery capabilities and rapid action By End User  Hospitals & ASCs: Largest segment due to high surgical volumes  Specialty Clinics  Others (research institutes, diagnostic centers) Regional Analysis North America leads the market, with strong growth driven by:  Advanced biotechnology developments  Sophisticated healthcare infrastructure  High volume of surgical procedures (700,000+ annual knee replacements) Market Leaders Key companies include:  Pfizer Inc.  Johnson & Johnson Services, Inc.  Grifols, S.A.  Baxter  Mochida Pharmaceutical Co., Ltd. Recent Strategic Developments

  2. March 2025: Shanghai RAAs Blood Products acquired Nanyue Biopharmaceutical for $584.2 million to enhance supply chain operations  April 2022: Grifols, S.A. acquired Biotest AG to expand its plasma products portfolio Market Drivers 1.Rising prevalence of bleeding disorders:  390,630 people worldwide affected by bleeding disorders  218,804 cases of hemophilia and Von Willebrand disease 2.Technological advancements:  Development of nanotechnology solutions like "SanguiStop"  Research into bioengineered delivery systems Market Challenges  High product costs ($321 for bovine thrombin-JMI 20,000 units)  Adverse drug reactions from different thrombin sources  Supply chain disruptions during COVID-19 Report- Fortune Business Insights - Thrombin Market Size, Share | Industry Growth Report [2032] https://www.fortunebusinessinsights.com/industry-reports/thrombin-market-100170

More Related